Analysts at Berenberg raised their target price on drugmaker Hikma Pharmaceuticals from 1,960.0p to 2,000.0p on Tuesday, citing more stability in its generics unit. "We adjusted our estimates to reflect slightly better generics earnings and our price target moves up to £20. Morgan Stanley downgraded Unilever on Tuesday to 'underweight' from 'equalweight' and cut its price target on the stock to 3,775.0p from 4,100.0p. RBC Capital Markets has reiterated an 'outperform' rating and 575p target price for Rentokil Initial ahead of the pest control group's full-year results next week. Barclays upgraded Flutter Entertainment on Tuesday to 'overweight' from 'equalweight' and lifted its price target to 200.0p from 153.0p, citing multi-year earnings growth.
